Search for a Cure
Coverage of the 2013 International AIDS Society Conference
- Details
- Category: HIV Treatment
- Published on Saturday, 06 July 2013 00:00
- Written by Liz Highleyman
HIVandHepatitis.com coverage of the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013), June 30-July 3, in Kuala Lumpur, Malaysia.
Conference highlights include antiretroviral therapy strategies, treatment access, investigational agents for HIV and hepatitis C, management of HIV-related complications, biomedical HIV prevention, and HIV cure research.
HIVandHepatitis.com IAS 2013 conference section
7/6/13
IAS 2013: Stem Cell Transplant Patients Remain HIV-Free [VIDEO]
- Details
- Category: Search for a Cure
- Published on Wednesday, 03 July 2013 00:00
- Written by Gregory Fowler
Two Boston men with HIV who received bone marrow transplants after a milder conditioning chemotherapy regimen continued to have undetectable virus 7 and 15 weeks after undergoing experimental treatment interruption, researchers reported at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this week in Kuala Lumpur.
IAS 2013: German Researchers Report Case of Functional Cure After Very Early HIV Treatment
- Details
- Category: Search for a Cure
- Published on Tuesday, 02 July 2013 00:00
- Written by Keith Alcorn
Another case of prolonged control of HIV replication after stopping treatment was reported on this week at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013), indicating that cases of post-treatment control of HIV are not confined to the French VISCONTI cohort.
IAS 2013: Boston Stem Cell Transplant Recipients Now Controlling HIV Off Treatment
- Details
- Category: Search for a Cure
- Published on Wednesday, 03 July 2013 00:00
- Written by Keith Alcorn
Two people with HIV who received stem cell transplants to treat lymphoma are now controlling HIV replication without antiretroviral medication in the early weeks of treatment interruption, following the discovery that both had experienced loss of detectable HIV DNA, researchers from Boston reported Wednesday at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) in Kuala Lumpur.
IAS 2013: Starting Treatment with CD4s Above 500 Reduces HIV Reservoir during Long-term Infection
- Details
- Category: Search for a Cure
- Published on Tuesday, 02 July 2013 00:00
- Written by Keith Alcorn
People with HIV who start treatment with CD4 counts above 500 cells/mm3, after the first phase of primary infection is over, are much more likely to experience substantial reductions in the reservoir of HIV-infected cells in their bodies, making them strong candidates for future studies that seek to control HIV without medication, French researchers reported at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this week in Kuala Lumpur.